← Leaderboards
Cimona V Hinton
Clark Atlanta University
$2,527,337
Attributed
$2,697,954
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $705K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,697,954 · 5
By mechanism
R01$1,196,566 · 1
U54$1,100,926 · 2
T32$341,235 · 1
F31$59,227 · 1
Top collaborators
- Conrad Ingram1 shared
Most similar at Clark Atlanta University
Same institution · by research overlap
- Valerie Odero-Marah$5,958,649
- Kimberly E. Davis$1,636,817
- Bekir Cinar$1,554,024
- Carlton E. Brown$0
- Shafiq Ahmed Khan$1,221,677
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsReportingMalignant NeoplasmsPrincipal InvestigatorResponseMaleCellsCell ProliferationCoupledCannabinoidsBoneCell MotilityAnimalsAffectAdverse EffectsComplementCancer CellAttenuatedBaseAgonistAllergic ReactionCancer TherapyAm 1241Cell Culture Techniques
Grant awards (11)
ADMINISTRATIVE CORE$390,997
U54 · FY2025 · MD · contact PI
CORE$313,955
U54 · FY2025 · MD · contact PI
ADMINISTRATIVE CORE$395,974
U54 · FY2024 · MD · contact PI
CAU G-RISE$341,235
T32 · FY2023 · GM · contact PI
Heterodimerization of CXCR4 and CB2 Inhibits Prostate Cancer Cell Movement$294,500
R01 · FY2016 · GM · contact PI
Heterodimerization of CXCR4 and CB2 Inhibits Prostate Cancer Cell Movement$294,500
R01 · FY2015 · GM · contact PI
Heterodimerization of CXCR4 and CB2 Inhibits Prostate Cancer Cell Movement$294,500
R01 · FY2014 · GM · contact PI
Matricelluar-mediated cell migration in tumor cells$18,566
R01 · FY2014 · GM · contact PI
Heterodimerization of CXCR4 and CB2 Inhibits Prostate Cancer Cell Movement$294,500
R01 · FY2013 · GM · contact PI
Heregulin Beta 1 Enhances Nuclear Localization of BRCA1$27,419
F31 · FY2004 · GM
Heregulin Beta 1 Enhances Nuclear Localization of BRCA1$31,808
F31 · FY2003 · GM